SMTL ID : 6x3n.1

Co-structure of BTK kinase domain with L-005085737 inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

1 x ULV: 4-{8-amino-3-[(6R,8aS)-3-oxohexahydro-3H-[1,3]oxazolo[3,4-a]pyridin-6-yl]imidazo[1,5-a]pyrazin-1-yl}-N-[4-(trifluoromethyl)pyridin-2-yl]benzamide(Non-covalent)

ULV.1: 19 residues within 4Å: Chain A: L.20, V.28, A.40, K.42, I.44, E.57, M.61, I.84, T.86, E.87, Y.88, M.89, G.92, C.93, N.96, L.140, S.150, D.151, L.154 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.28, A:V.28, A:K.42, A:K.42, A:E.57, A:T.86, A:L.140, A:L.154 Hydrogen bonds: A:E.87, A:M.89, A:C.93, A:N.96, A:D.151

1 x 5WE: 4-[8-azanyl-3-[(2~{S})-1-[4-(dimethylamino)butanoyl]pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-~{N}-(1,3-thiazol-2-yl)benzamide(Non-covalent)

5WE.2: 8 residues within 4Å: Chain A: S.6, W.7, I.9, W.33, Y.37, V.39, S.65, Y.73 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:W.33, A:W.33, A:Y.37, A:Y.37, A:V.39, A:Y.73, A:Y.73, A:Y.73 Hydrogen bonds: A:S.65

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, J. et al., Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutes. Bioorg.Med.Chem.Lett. (2020)

Release Date

2020-07-22

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence